National Research Corporation

NASDAQ:NRC

Medical - Healthcare Information Services

Healthcare
$26.16 +0.40%

+$0.07 today

Market cap
$555.16M
Beta
0.40
P/E (TTM)
43.0
EPS (TTM)
$0.41
Dividend yield
3.14%
52W Low $11.01High $22.79

Volume 0.09M

Average 0.11M

NRC Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

National Research CorporationNASDAQ: NRC

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables turns positive

Q1 FY2026 accounts receivables was $275K, compared with -$272K a year earlier. Trailing-twelve-month accounts receivables was $494K. Over 3 fiscal years it compounded at -58.3% a year.

Context

  • Accounts receivables amounted to 0.0% of revenue in FY2025, down 1.2 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts receivables holds near $275K or moves back toward the trailing-twelve-month quarterly average of $123.5K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$275K-83.2% QoQ
Last fiscal yearDec 2025
-$53K-103.0% YoY
LTMMar 2026
$494K+111.1% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+201.1%——
1 year-103.0%——
3-year CAGR-58.3%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(53K) USD
Year-over-year change
-103.0%

Accounts Receivables vs competitors

How NRC compares with its peers on the latest reported figures

  • NRC's LTM Mar 2026 accounts receivables of $494K is the smallest of the 8 companies compared; the peer median is $1.17M.
  • Its year-over-year change of +111.1% is the 5th highest of 8, against a peer median of +163.3%.
  • Accounts receivables amounts to 0.4% of revenue for NRC, versus a peer median of 1.8%.
NRC Competitors Peer median
Accounts Receivables for NRC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CTEVClaritev CorporationLTM Mar 2026$38.91M +252.9%—4.0%
HSTMHealthStream, Inc.LTM Mar 2026$7.53M -241.6%-20.0%2.4%
PHRPhreesia, Inc.LTM Apr 2026$6.91M +177.6%-3.0%1.4%
DHDefinitive Healthcare Corp.LTM Mar 2026$4.29M -67.1%—1.8%
HCATHealth Catalyst, Inc.LTM Mar 2026$3.67M +163.3%—1.2%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$3.43M -549.9%—4.2%
CCLDCareCloud, Inc.LTM Mar 2026$1.17M +191.7%-42.5%0.9%
NRCNational Research CorporationLTM Mar 2026$494K +111.1%-58.3%0.4%
Peer median (excluding NRC) $1.17M+163.3%-20.0%1.8%

Competitors are the stored peer set for NRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income37.47M31.8M30.97M24.78M11.6M
Depreciation & Amortization6.37M5.28M5.9M6.02M7.62M
Deferred Income Tax33K(1.24M)(717K)(406K)2.45M
Stock-Based Compensation623K1.2M935K284K3.31M
Change in Working Capital1.84M(3.35M)1.03M3.84M916K
Accounts Receivables343K(733K)2.08M1.76M(53K)
Inventory00000
Accounts Payables4K(589K)184K(108K)170K
Other Working Capital1.49M(2.03M)(1.24M)2.19M799K
Other Non-Cash Items7K2.58M(102K)100K545K
Operating Cash Flow46.34M36.27M38.11M34.63M26.45M
Capital Expenditures(5.51M)(9.84M)(15.78M)(15.45M)(10.71M)
Acquisitions (Net)(3M)00(4.83M)0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities001K00
Investing Cash Flow(8.51M)(9.84M)(15.78M)(20.28M)(10.71M)
Debt Repayment(4.59M)(4.77M)14.18M25.99M16.11M
Common Stock Issued0000132K
Common Stock Repurchased(4.14M)(27.62M)(19.1M)(30.95M)(20.18M)
Dividends Paid(9.16M)(20.96M)(36.37M)(11.45M)(10.98M)
Other Financing Activities(275K)(2.04M)576K(359K)(923K)
Financing Cash Flow(18.16M)(55.58M)(40.71M)(16.76M)(15.84M)
Effect of Forex Changes3K(182K)(1K)00
Net Change in Cash19.67M(29.34M)(18.37M)(2.42M)(94K)
Free Cash Flow40.83M26.43M22.33M19.18M15.74M

National Research Corporation

NASDAQ:NRC

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.